In the rapidly evolving healthcare arena, Carter Morse & Mathias has provided transaction expertise to privately held middle market companies across multiple industry sectors including health care services, health care IT, medical devices, and biopharmaceuticals.
We offer a full range of investment banking services: business sales and divestitures, equity and debt capital raises, strategic acquisitions, and pre-transaction and strategic advisory services.
"CMM co-founded Thetis and has played a key role from day one. They exceeded our expectations in raising our first round of capital and serve as interim CFO. Carter Morse & Mathias is a true partner in this venture."
Frank Sciavolino President and Chief Scientific Officer Thetis Pharmaceuticals LLC
Securities are offered through Carter Capital Corporation, memberFINRA and SIPC.
This information should not be construed as a recommendation, offer to sell, or solicitation of an offer to buy a particular security or investment strategy. The commentary provided is for informational purposes only and should not be relied on for accounting, legal, tax or other professional advice. While the information herein is deemed reliable, CMM cannot guarantee its accuracy, completeness, or suitability for any purpose, and makes no warranties with regard to the results to be obtained from its use.